A selection of the times Clínica Synaptica has appeared in the media. Each card summarises the mention in our own words and links to the original outlet.
Before the Approvals Arrive: Norway, Germany, Switzerland, the UK and Estonia at TAIP Conference 2026
Report on the TAIP conference that mentions the international summit held in Barcelona from 16 to 18 October and links to the Clínica Synaptica page.
Why only one psychedelic therapy is legal in Spain
Newsletter by Oriol Roda that cites Òscar Parés as director of Clínica Synaptica and recommends Barcelona's first international summit on assisted psychotherapy.
487 Records, 27 Countries. What PsyAccess Reveals About Psychedelic Care in Europe
Analysis of the PsyAccess directory on psychedelic care in Europe. It presents Clínica Synaptica and its founder, Òscar Parés.
José Carlos Bouso Saiz, psychedelic psychologist: “Psychedelics teach you that you can be alive without suffering”
La Contra interview with José Carlos Bouso on psychedelic medicine and mental health. It presents him as a member of Synaptica, the first clinic of its kind in Spain.
Albert's Notebook: microdosing and psychedelics, now the journey comes with a reservation
Article from Albert's Notebook on microdosing and psychedelics that refers to José Carlos Bouso's profile at Synaptica among its sources.
How to Choose a Psychedelic Therapy Clinic Offering Guided Sessions
Anna Lindner's guide to choosing a psychedelic therapy clinic. It uses Clínica Synaptica as an example and includes the experience of Òscar Parés and Marta Martín Islas.
Synaptica in Barcelona, a mental health centre specialising in psychedelic therapy
Feature by Fidel Moreno on the clinic: how its team works, its views on safety, costs and the role of public healthcare, and how it trains other professionals. Includes interviews with Òscar Parés, Joan Obiols and Irene Pérez.
I interview Óscar Parés: from Energy Control to psychedelic therapy, a life defending your right to decide
Conversation with Synaptica's founder about his path from harm reduction and drug policy to psychedelic therapy, and about why he believes prohibition does not work.
Assisted therapy makes its way in Europe despite stigma and legal uncertainty
Article from the legal communication and marketing blog of Abogacía Española on the legal status of these therapies. It recalls that Clínica Synaptica, the first clinic of its kind, opened in Barcelona in 2022.
The 4th LasDrogas.info Conference addresses the rise of psychedelics in mental health
Announces an online conference in which José Carlos Bouso, scientific director of Clínica Synaptica, takes part in the panel on how to integrate these therapies into clinical practice and public health.
J.C. Bouso, psychedelics researcher: “It is a paradox that the right is the one most supporting these substances”
Pol Pareja's interview with José Carlos Bouso on the political and scientific rise of psychedelics. It presents him as scientific director of Clínica Synaptica.
Research at the margins: scientist José Carlos Bouso and his study on addictions
Feature by Oihan Iturbide on the research of scientist José Carlos Bouso, scientific director of Synaptica, into the treatment of addictions.
Psychedelics and mental health: questions and answers on their research
Question-and-answer document for journalists on what psychedelics are, their research and their legal status in Spain, with the opinion of José Carlos Bouso as an expert from Clínica Synaptica. Also reproduced by Eje Público and Punto de Quiebre.
Are hallucinogenic substances the future of mental health treatment?
EFE feature on psychedelic therapies with José Carlos Bouso, scientific director of the Synaptica clinic.
Postcard #4 Joan Obiols and JC Bouso climb aboard the Eutopías ship
A 35-minute episode of the Eutopías podcast with Dr Joan Obiols and José Carlos Bouso, tagged with Clínica Synaptica, on mental health and psychedelics.
Postcard #3 We explore preparing for the psychedelic experience
A 22-minute episode of the Eutopías podcast on how to prepare for the experience, with Irene Pérez, somatic therapist and art therapist at Clínica Synaptica, among the guests.
Bouso, the sage of psychedelic therapy
Profile of José Carlos Bouso, scientific director of the ICEERS foundation and of Clínica Synaptica, on the future and cost of psychedelic therapies.
Science revives the therapeutic potential of psychoactives
Article by Beatriz Rivera on the therapeutic potential of psychoactives that presents Òscar Parés's Synaptica clinic as the first centre of this kind in Barcelona.
Psychedelic-Assisted Psychotherapies in Europe: Legal Challenges and Horizons
Opinion piece signed by Òscar Parés, founder and CEO of Clínica Synaptica, on the legal challenges of assisted psychotherapy in Europe.
Second edition of Clínica Synaptica's training for professionals in Barcelona
International press release (via PR Newswire) from Clínica Synaptica and a US research foundation on the second edition of its training for professionals, with Joan Obiols's team and statements from Òscar Parés. Also distributed by PR Newswire, StreetInsider and The AI Journal.
Interview with Óscar Parés: psychotherapy and psychedelics, a new axis of mental health treatment
Interview with Synaptica's founder, who argues for combining medication and psychotherapy in disorders that do not respond to conventional treatments, such as depression.
Assisted therapy in practice: I interview Marta Martín of Clínica Synaptica
Interview by the Mujeres Psicodélicas podcast with Marta Martín, a psychologist at Clínica Synaptica for more than three years, about her work and her training in acceptance and commitment therapy.
Psychedelic drugs, a scientific revolution from the laboratory to the couch
Feature on the return of psychedelic research, citing Clínica Synaptica as an example of a centre with more than 300 patients from more than 30 countries. Also published in the Galician edition, O Salto.
The advance of the therapeutic use of psychedelic drugs in Spain: a “very promising future” despite the barriers
Feature by Santiago F. Reviejo on the progress of psychedelic therapies in Spain that cites the private clinic Synaptica in Barcelona and José Carlos Bouso, clinical psychologist and scientific director of ICEERS.